MedPath

Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery

Completed
Conditions
Meibomian Gland Dysfunction
Registration Number
NCT01942642
Lead Sponsor
Yonsei University
Brief Summary

Meibomian gland dysfunction (MGD) is a common and important disease has been investigated the pathophysiology, diagnosis, treatment modalities of MGD, however, the changes of MGD after the cataract surgery, the most popular surgery to ophthalmologist, had not been evaluated. The investigators evaluated parameters related with MGD including lid margin abnormalities, meibomian gland expressibility and meibography before and after surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  1. Patients scheduled for cataract surgery
Read More
Exclusion Criteria
  1. other comorbid ocular diseases such as ocular allergies.
  2. continuous use of topical ocular medications before surgery
  3. histories of ocular surgery, or ocular injury
  4. Already had severe obstructive MGD before surgery, abnormal findings on lid margin (> 3 positive findings), reduced meibum expression (> grade 2), and obstructed gland dropout (meibography score > 3)
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ocular parameterschange of Ocular parameters from 1 to 3 months after cataract surgery

Ocular symptom score, lid margin abnormalities, superficial punctuate keratopathy, tear film break-up time, Shirmer's test, lower tear meniscus height (TMH), depth (TMD), and area (TMA), meibum expressibility, and meibography score

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath